These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 22439881)
1. Synthesis, binding affinity, and functional in vitro activity of 3-benzylaminomorphinan and 3-benzylaminomorphine ligands at opioid receptors. Neumeyer JL; Zhang B; Zhang T; Sromek AW; Knapp BI; Cohen DJ; Bidlack JM J Med Chem; 2012 Apr; 55(8):3878-90. PubMed ID: 22439881 [TBL] [Abstract][Full Text] [Related]
2. Comparison of pharmacological activities of three distinct kappa ligands (Salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo. Wang Y; Tang K; Inan S; Siebert D; Holzgrabe U; Lee DY; Huang P; Li JG; Cowan A; Liu-Chen LY J Pharmacol Exp Ther; 2005 Jan; 312(1):220-30. PubMed ID: 15383632 [TBL] [Abstract][Full Text] [Related]
4. Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys. Ko MC; Lee H; Harrison C; Clark MJ; Song HF; Naughton NN; Woods JH; Traynor JR J Pharmacol Exp Ther; 2003 Jul; 306(1):179-86. PubMed ID: 12676881 [TBL] [Abstract][Full Text] [Related]
5. Further Optimization and Evaluation of Bioavailable, Mixed-Efficacy μ-Opioid Receptor (MOR) Agonists/δ-Opioid Receptor (DOR) Antagonists: Balancing MOR and DOR Affinities. Harland AA; Yeomans L; Griggs NW; Anand JP; Pogozheva ID; Jutkiewicz EM; Traynor JR; Mosberg HI J Med Chem; 2015 Nov; 58(22):8952-69. PubMed ID: 26524472 [TBL] [Abstract][Full Text] [Related]
6. Effect of N-alkyl and N-alkenyl substituents in noroxymorphindole, 17-substituted-6,7-dehydro-4,5alpha-epoxy-3,14-dihydroxy-6,7:2',3'-indolomorphinans, on opioid receptor affinity, selectivity, and efficacy. McLamore S; Ullrich T; Rothman RB; Xu H; Dersch C; Coop A; Davis P; Porreca F; Jacobson AE; Rice KC J Med Chem; 2001 Apr; 44(9):1471-4. PubMed ID: 11311071 [TBL] [Abstract][Full Text] [Related]
7. Agonist activity of naloxone benzoylhydrazone at recombinant and native opioid receptors. Olianas MC; Concas D; Onali P Br J Pharmacol; 2006 Feb; 147(4):360-70. PubMed ID: 16402046 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of 6alpha- and 6beta-N-heterocyclic substituted naltrexamine derivatives as mu opioid receptor selective antagonists. Li G; Aschenbach LC; Chen J; Cassidy MP; Stevens DL; Gabra BH; Selley DE; Dewey WL; Westkaemper RB; Zhang Y J Med Chem; 2009 Mar; 52(5):1416-27. PubMed ID: 19199782 [TBL] [Abstract][Full Text] [Related]
9. 6β-N-Heterocyclic Substituted Naltrexamine Derivative BNAP: A Peripherally Selective Mixed MOR/KOR Ligand. Williams DA; Zheng Y; David BG; Yuan Y; Zaidi SA; Stevens DL; Scoggins KL; Selley DE; Dewey WL; Akbarali HI; Zhang Y ACS Chem Neurosci; 2016 Aug; 7(8):1120-9. PubMed ID: 27269866 [TBL] [Abstract][Full Text] [Related]